SEC Filings

Document Details

Form
Filing Date
Jun 19, 2018
Document Date
Jun 19, 2018
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Aimmune Therapeutics
Issuer
Allergen Research Corp